Federal officials announced new funding on Thursday to explore the medical potential of ibogaine, a controversial psychedelic drug. The substance has gained a vocal following among veterans, conservative lawmakers, and podcasters aligned with President Donald Trump. The announcement marks a notable step in bringing the drug into the realm of formal medical research.
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
